Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
did not know if that meant just that patients received just the adjuvant or half of the reconstituted vaccine; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete dose administered in a male patient who received Herpes zoster (Shingrix) for prophylaxis. In JUN-2025, the patient received Shingrix. In JUN-2025, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: did not know if that meant just that patients received just the adjuvant or half of the reconstituted vaccine). The outcome of the incomplete dose administered was not applicable. Additional Information: GSK receipt date: 24-SEP-2025 Physician stated that patient received half a dose of Shingrix instead of the full dose, she did not know if that meant just that patients received just the adjuvant or half of the reconstituted vaccine. Also stated that dates of administration were between 23-JUN-2025 to 27-JUN-2025. This case is one of the linked cases reported by the same reporter.; Sender's Comments: US-GSK-US2025122806:Same reporter/Different patient US-GSK-US2025122813: